What is the Share Price of Bharat Parenterals Ltd?

Bharat Parenterals Ltd share price is ₹1,100 As on 09 May, 2025|09:16

Home
>
Stocks
>
Bharat Parenterals Ltd

Bharat Parenterals Ltd Share Price

Q: What is the Market Cap of Bharat Parenterals Ltd?

The Market Cap of Bharat Parenterals Ltd is ₹766 As on 09 May, 2025|09:16

Q: What is PE Ratio of Bharat Parenterals Ltd?

The P/E ratio of Bharat Parenterals Ltd is 7.78 As on 09 May, 2025|09:16

Q: What is PB Ratio of Bharat Parenterals Ltd?

The PB ratio of Bharat Parenterals Ltd is 4.64 As on 09 May, 2025|09:16

₹ 0.00 0 (0%)
Updated on 01-01-1970 5:30 AM

Stock Rating

BSE

Pros 2

Cons 5

Bharat Parenterals Ltd Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

Its last traded stock price on BSE was 1,100 down by -3.81%. The total volume of shares on NSE and BSE combined was 3,783 shares. Its total combined turnover was Rs 0.44 crores.

Bharat Parenterals Ltd Medium and Long Term Market Action

The stock price of Bharat Parenterals Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Bharat Parenterals Ltd Fundamentals

Market Cap (Cr): 766
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Bharat Parenterals Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Bharat Parenterals Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Bharat Parenterals Ltd

Data not available.

Bharat Parenterals Ltd FAQ's

What is Share Price of Bharat Parenterals Ltd?

What is the Market Cap of Bharat Parenterals Ltd?

What is PE Ratio of Bharat Parenterals Ltd?

What is PB Ratio of Bharat Parenterals Ltd?

What is the CAGR of Bharat Parenterals Ltd?

How to Buy Bharat Parenterals Ltd Share?

Can I buy Bharat Parenterals Ltd from Samco?

How do I buy Bharat Parenterals Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Above Average Sustainable RoE
The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
Asset Light Business
The company operates a great asset light business with a high Asset turnover ratio of 5.56. A high asset turnover ratio is a great driver of RoE and can improve shareholder returns. A relatively higher asset turnover ratio also will result in lower dilution as the business grows its revenues as earnings.

Cons

Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only -56.10% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Low Interest Coverage
The company has a very low Interest coverage ratio of 7.25 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 411 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(09/05/2025)

Margin of Safety Index: High

100.00%

100.00% People are bullish about Bharat Parenterals Ltd

0.00%

0.00 % People are bearish about Bharat Parenterals Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %